1. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW (2001) Oncogene 20(8): 910-20
    › Primary publication · 11314026 (PubMed)
  2. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL (2001) Oncogene 20(48): 6983-93
    › Primary publication · 11704823 (PubMed)
  3. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression. Nip J, Hiebert SW (2000) Cell Biochem Biophys 33(2): 199-207
    › Primary publication · 11325040 (PubMed)
  4. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Melnick AM, Westendorf JJ, Polinger A, Carlile GW, Arai S, Ball HJ, Lutterbach B, Hiebert SW, Licht JD (2000) Mol Cell Biol 20(6): 2075-86
    › Primary publication · 10688654 (PubMed) · PMC110824 (PubMed Central)
  5. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW (2000) Mol Cell Biol 20(16): 5828-39
    › Primary publication · 10913166 (PubMed) · PMC86060 (PubMed Central)
  6. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Lutterbach B, Hiebert SW (2000) Gene 245(2): 223-35
    › Primary publication · 10717473 (PubMed)
  7. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. Javed A, Guo B, Hiebert S, Choi JY, Green J, Zhao SC, Osborne MA, Stifani S, Stein JL, Lian JB, van Wijnen AJ, Stein GS (2000) J Cell Sci : 2221-31
    › Primary publication · 10825294 (PubMed)
  8. Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle. Strom DK, Nip J, Westendorf JJ, Linggi B, Lutterbach B, Downing JR, Lenny N, Hiebert SW (2000) J Biol Chem 275(5): 3438-45
    › Primary publication · 10652337 (PubMed)
  9. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein. Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD (2000) Blood 96(12): 3939-47
    › Primary publication · 11090081 (PubMed)
  10. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW (2000) J Biol Chem 275(1): 651-6
    › Primary publication · 10617663 (PubMed)